A new optogenetics study finds that stimulation of pro-opiomelanocortin (POMC) and agouti-related peptide (AGRP) neurons acutely regulates feeding behavior. AGRP-induced hyperphagia is independent of melanocortin signaling.
It could be argued that the hypothalamus was initially implicated in the control of food intake and obesity nearly 170 years ago with the first clinical description, by Bernhard Mohr, of hypo thalamicpituitary injury resulting in obesity 1 . At the turn of the twentieth century, Joseph Babinski and Alfred Frolich also reported a con dition of obesity and retarded sexual develop ment was attributed to hypothalamicpituitary injury 1 . In the past century, several reports have advanced the concept that the hypothalamus is required for the regulation of energy balance 1, 2 . Despite these seminal observations, throughout the decades contemporary methodologies have been a limiting factor in determining the physio logical effects of perturbing signaling in vivo at the cellular and/or circuit level. In this issue of Nature Neuroscience, Aponte and colleagues 3 use mouse optogenetics to probe neural circuits in the arcuate nucleus of the hypothalamus and find that POMC and AGRP neurons have counterregulatory roles on the regulation of food intake.
Aponte et al. 3 took advantage of channel rhodopsin2 (ChR2) to alter neuronal activ ity and extend previous observations in an attempt to determine whether neurons that produce AGRP and neuropeptide Y (NPY) can acutely regulate food intake. ChR2, iso lated from Chlamydomonas reinhardtii, was used previously 4 to rapidly and robustly control neuronal activity. ChR2 absorbs blue (480 nM) light, which induces a conforma tional change that opens the channel pore, permitting ions to flow, causing a depolar ization and ultimately resulting in increased action potentials. In the brief time since the introduction of optogenetics, this technique has found widespread use in neuroscience, including studies that range from expand ing our understanding of basic neuroscience principles to investigating neuropsychiat ric disorders such as Parkinson's disease 4 (Fig. 1) . Activation of AGRP neurons resulted in an acute, frequency dependent increase in food intake; however, the acute hyperphagia was independent of melanocortin signaling, supporting a previ ously identified role of GABA in mediating the acute starvation ( Fig. 1) 6 . n e w s a n d v i e w s n e w s a n d v i e w s with this observation, recent work found that AGRP neurons regulate food intake and energy balance independent of melanocortin signaling 6, 11 . Specifically, selective deletion of the vesicular GABA transporter (Vgat) from AGRP neurons using Cre-loxP resulted in mice that are lean and resistant to highfat diet (HFD)induced obesity, but with no major effect on food intake, similar to mice with neo natal ablation of AGRP neurons 11 . The lean pheno type is a result of increased locomotor activity, whereas an increased HFDinduced thermogenesis contributes to the resistance of HFDinduced obesity. Notably, these mice do show an attenuated hyperphagic response to ghrelin, which was attributed to an inability of AGRP neurons to antagonize POMC neuronal activity. Moreover, it was also reported that AGRP neurons modify food intake at least in part through a GABAergic regulation of the parabrachial nucleus (Fig. 1 ) 6 . The current study by Aponte et al. 3 is also quite notable in that it provides a bona fide functional corre late (that is, feeding behavior) with altered neuronal firing. These results can now be integrated with several in vitro slice studies demon strating that AGRP and NPY neurons alter their firing rates when metabolically relevant signals are applied to the slice (for example, ghrelin, leptin or serotonin) 2 . Not surprisingly, these results also raise several questions for future investigation. In addition to regulating energy balance, the mediobasal hypothalamus has been of intense interest in the regulation of glucose homeostasis 12, 13 . In 1849, Claude Bernard suggested that the brain regulates blood glu cose levels and suggested that this effect was dependent on stimulation of sympathetic innervation of the liver. However, few have been able to further elucidate this finding until recently available molecular techniques have narrowed possible cell populations in the brain that may be responsible for these effects on blood glucose. For instance, an early report suggested overexpression of the Pomc gene lowered blood glucose in mice 2, 14 . Opposing these reports of POMCinduced regulation of glucose homeostasis, several studies suggest little if any involvement of NPY and AGRP neurons on glucose homeostasis 2 . In addition, both POMC and NPY and AGRP neurons have been implicated in the regulation of processes A key advance of the work of Aponte et al. 3 is that it highlights the importance of the temporal regulation of AGRP and POMC neuronal activity. This temporal regulation is manifest in at least two mechanisms, one long term and the other acute. The longterm issue relates to the potential for develop mental 'compensation' when genes are inacti vated using standard or conditional knockout approaches. For example, recent reports have generated some confusion over the role of NPY and AGRP neurons in the regulation of food intake 6 . Although a conventional knockout in the mouse of either POMC, which is the pre cursor of αmelanocyte stimulating hormone (αMSH), or its downstream receptors (MC 3 or MC 4 ) causes hyperphagia and obesity, a con ventional knockout of either NPY or AGRP results in normal body weight, adiposity and food intake [7] [8] [9] . In addition, toxinmediated ablation of NPY and AGRP neurons early in development results in only modest changes in food intake 6 . However, ablation of NPY and AGRP neurons in adult mice causes acute hypophagia and a reduction in body weight 6, 10 . Notably, the acute ablation kills the target cells entirely, whereas, in the conventional knockout models, the mice lack only the specified peptide and the neurons are therefore still present in the CNS. This suggests that there is the potential for compensatory mechanisms independent of NPY and AGRP in the conventional knockout models that may account for the regulation of food intake. Some recent work suggests that the neurotransmitter GABA, which is colocalized in NPY and AGRP neurons, may be critical for regulating food intake and/or energy balance 6 . Collectively, these observations further demon strate that there are inherent limitations in approaches using mice that develop while either lacking or overexpressing key proteins of interest. Moving forward, approaches such as that used by Aponte et al. 3 , in combination with newer inducible Cre models, will help us understand how motivated behaviors such as feeding are regulated.
The second important advance of the Aponte et al.'s study 3 relates to a much smaller temporal window. Specifically, their results highlight the importance of acute neuronal activity in regulating feeding behaviors, especially those behaviors medi ated by classic neurotransmitters. Consistent that include reward, addiction, locomotor activity and energy expenditure 2, 15 . However, owing to earlier technological limitations, their roles have not been completely defined. Thus, the current optogenetic strategy has great potential to delineate the dependence of many modalities on both POMC and NPY/ AGRP neurons.
In summary, from the time of Mohr, Bernard, Babinski and Frolich, the field of obesity and diabetes research has seen sub stantial progress in understanding the neural mechanisms involved in the regulation of energy and glucose homeostasis. Through the decades, our understanding has been restricted as a result of inherent limitations in available techniques. Aponte et al. 3 extend previous observations in the field with the use of a stateoftheart optogenetics stra tegy to functionally probe neural circuits in the medial basal hypo thalamus. Clearly, the authors have expanded our current under standing of the arcuatebased network of POMC and NPY and AGRP neurons. Although much is left to be learned, with this new technology in hand, the future of hypo thalamic research is clearly bright.
